Shopping Cart 0
Cart Subtotal
USD 0

Inivata Ltd - Product Pipeline Analysis, 2019 Update

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
USD 750

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
USD 1500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
USD 2250

Details

Summary

Inivata Ltd (Inivata) is a cancer genomics company that harnesses liquid biopsy platform to enhance personalized healthcare in oncology. The company's product portfolio includes InVisionFirst-Lung, which offers advanced sequencing technology to detect copy number variants, single nucleotide variants, insertions and deletions and structural variants in selected genes from DNA isolated from plasma samples from patients with non-small cell lung cancer; and InVisionSeq test. Inivata works with industry and academic researchers to develop new clinical applications for liquid biopsy and ctDNA analysis. The company operates in the UK and the US. Inivata is headquartered in Cambridge, Cambridgeshire, the UK.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company Inivata Ltd

- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

- The report provides detailed description of products in development, technical specification and functions

- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

- To formulate effective Research & Development strategies

- Develop market-entry and market expansion strategies

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents

List of Tables

List of Figures

Inivata Ltd Company Overview

Inivata Ltd Company Snapshot

Inivata Ltd Pipeline Products and Ongoing Clinical Trials Overview

Inivata Ltd-Pipeline Analysis Overview

Inivata Ltd-Key Facts

Inivata Ltd-Major Products and Services

Inivata Ltd Pipeline Products by Development Stage

Inivata Ltd Ongoing Clinical Trials by Trial Status

Inivata Ltd Pipeline Products Overview

InVision ctDNA Assay-EGFR-Mutant NSCLC

InVision ctDNA Assay-EGFR-Mutant NSCLC Product Overview

InVision ctDNA Assay-Metastatic Breast Cancer

InVision ctDNA Assay-Metastatic Breast Cancer Product Overview

InVision ctDNA Assay-NSCLC

InVision ctDNA Assay-NSCLC Product Overview

InVision ctDNA Assay-NSCLC Clinical Trial

InVision ctDNA Assay-Pancreatic Cancer

InVision ctDNA Assay-Pancreatic Cancer Product Overview

InVision ctDNA Assay-Stage III/IV NSCLC

InVision ctDNA Assay-Stage III/IV NSCLC Product Overview

InVision First-Lung

InVision First-Lung Product Overview

InVision First-Lung Clinical Trial

Inivata Ltd-Key Competitors

Inivata Ltd-Key Employees

Inivata Ltd-Locations And Subsidiaries

Head Office

Recent Developments

Inivata Ltd, Recent Developments

Aug 12, 2019: Inivata appoints Jacqui Watson as Chief People Officer

Jul 18, 2019: Inivata announces launch of clinical trial to evaluate impact of InVisionFirst-Lung liquid biopsy test on time to appropriate treatment in advanced lung cancer

Apr 26, 2019: Inivata publishes positive clinical validation results and real-world utility for its InVisionFirst-Lung liquid biopsy test

Apr 16, 2019: Genomics England and industry partners complete first phase of liquid biopsy study

Mar 07, 2019: Inivata publishes positive results of clinical validation and utility study for InVision Liquid Biopsy Test

Mar 05, 2019: Inivata receives medicare final coverage decision for InVisionFirst-Lung Liquid Biopsy test in advanced Non-Small Cell Lung Cancer

Dec 20, 2018: Inivata names Charlie Kesinger as Chief Information Officer

Sep 24, 2018: Inivata to Present Results of Prospective Clinical Validation Study of its InVisionFirst-Lung Liquid Biopsy Test in Advanced Non-Small Cell Lung Cancer at the World Conference on Lung Cancer

Sep 13, 2018: Inivata achieves major milestone with draft medicare local coverage determination (LCD) for InVisionFirst-lung liquid biopsy test

Sep 12, 2018: Inivata announces senior management change

Appendix

Methodology

About GlobalData

Contact Us

Disclaimer


List Of Figure

List of Figures

Inivata Ltd Pipeline Products by Equipment Type

Inivata Ltd Pipeline Products by Development Stage

Inivata Ltd Ongoing Clinical Trials by Trial Status


List Of Table

List of Tables

Inivata Ltd Pipeline Products and Ongoing Clinical Trials Overview

Inivata Ltd Pipeline Products by Equipment Type

Inivata Ltd Pipeline Products by Indication

Inivata Ltd Ongoing Clinical Trials by Trial Status

Inivata Ltd, Key Facts

Inivata Ltd, Major Products and Services

Inivata Ltd Number of Pipeline Products by Development Stage

Inivata Ltd Pipeline Products Summary by Development Stage

Inivata Ltd Ongoing Clinical Trials by Trial Status

Inivata Ltd Ongoing Clinical Trials Summary

InVision ctDNA Assay-EGFR-Mutant NSCLC-Product Status

InVision ctDNA Assay-EGFR-Mutant NSCLC-Product Description

InVision ctDNA Assay-Metastatic Breast Cancer-Product Status

InVision ctDNA Assay-Metastatic Breast Cancer-Product Description

InVision ctDNA Assay-NSCLC-Product Status

InVision ctDNA Assay-NSCLC-Product Description

InVision ctDNA Assay-NSCLC-Liquid Biopsy in Early Stage NSCLC Resected Lung Tumor Investigation: LIBERTI

InVision ctDNA Assay-Pancreatic Cancer-Product Status

InVision ctDNA Assay-Pancreatic Cancer-Product Description

InVision ctDNA Assay-Stage III/IV NSCLC-Product Status

InVision ctDNA Assay-Stage III/IV NSCLC-Product Description

InVision First-Lung-Product Status

InVision First-Lung-Product Description

InVision First-Lung-A Randomized Phase III Clinical Trial to Evaluate the Feasibility and Clinical Relevance of Liquid Biopsy in Patients with Suspicious Metastatic Lung Cancer

InVision First-Lung-Analytical Validation of a Next Generation Sequencing Liquid Biopsy Assay for High Sensitivity Broad Molecular Profiling

InVision First-Lung-Evaluation of Liquid Biopsies for Molecular Profiling in Patients with Advanced Non-small Cell Lung Cancer (NSCLC) in the Relapse Treatment Setting

Inivata Ltd, Key Employees

Glossary

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

Inivata Ltd, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies


Companies

DiagNodus Ltd

ANGLE Plc

Binx Health Inc

Company Profile

Company Profile Title

Summary

Inivata Ltd (Inivata) is a cancer genomics company that harnesses liquid biopsy platform to enhance personalized healthcare in oncology. The company's product portfolio includes InVisionFirst-Lung, which offers advanced sequencing technology to detect copy number variants, single nucleotide variants, insertions and deletions and structural variants in selected genes from DNA isolated from plasma samples from patients with non-small cell lung cancer; and InVisionSeq test. Inivata works with industry and academic researchers to develop new clinical applications for liquid biopsy and ctDNA analysis. The company operates in the UK and the US. Inivata is headquartered in Cambridge, Cambridgeshire, the UK.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company Inivata Ltd

- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

- The report provides detailed description of products in development, technical specification and functions

- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

- To formulate effective Research & Development strategies

- Develop market-entry and market expansion strategies

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Scope

Table of Contents

Table of Contents

List of Tables

List of Figures

Inivata Ltd Company Overview

Inivata Ltd Company Snapshot

Inivata Ltd Pipeline Products and Ongoing Clinical Trials Overview

Inivata Ltd-Pipeline Analysis Overview

Inivata Ltd-Key Facts

Inivata Ltd-Major Products and Services

Inivata Ltd Pipeline Products by Development Stage

Inivata Ltd Ongoing Clinical Trials by Trial Status

Inivata Ltd Pipeline Products Overview

InVision ctDNA Assay-EGFR-Mutant NSCLC

InVision ctDNA Assay-EGFR-Mutant NSCLC Product Overview

InVision ctDNA Assay-Metastatic Breast Cancer

InVision ctDNA Assay-Metastatic Breast Cancer Product Overview

InVision ctDNA Assay-NSCLC

InVision ctDNA Assay-NSCLC Product Overview

InVision ctDNA Assay-NSCLC Clinical Trial

InVision ctDNA Assay-Pancreatic Cancer

InVision ctDNA Assay-Pancreatic Cancer Product Overview

InVision ctDNA Assay-Stage III/IV NSCLC

InVision ctDNA Assay-Stage III/IV NSCLC Product Overview

InVision First-Lung

InVision First-Lung Product Overview

InVision First-Lung Clinical Trial

Inivata Ltd-Key Competitors

Inivata Ltd-Key Employees

Inivata Ltd-Locations And Subsidiaries

Head Office

Recent Developments

Inivata Ltd, Recent Developments

Aug 12, 2019: Inivata appoints Jacqui Watson as Chief People Officer

Jul 18, 2019: Inivata announces launch of clinical trial to evaluate impact of InVisionFirst-Lung liquid biopsy test on time to appropriate treatment in advanced lung cancer

Apr 26, 2019: Inivata publishes positive clinical validation results and real-world utility for its InVisionFirst-Lung liquid biopsy test

Apr 16, 2019: Genomics England and industry partners complete first phase of liquid biopsy study

Mar 07, 2019: Inivata publishes positive results of clinical validation and utility study for InVision Liquid Biopsy Test

Mar 05, 2019: Inivata receives medicare final coverage decision for InVisionFirst-Lung Liquid Biopsy test in advanced Non-Small Cell Lung Cancer

Dec 20, 2018: Inivata names Charlie Kesinger as Chief Information Officer

Sep 24, 2018: Inivata to Present Results of Prospective Clinical Validation Study of its InVisionFirst-Lung Liquid Biopsy Test in Advanced Non-Small Cell Lung Cancer at the World Conference on Lung Cancer

Sep 13, 2018: Inivata achieves major milestone with draft medicare local coverage determination (LCD) for InVisionFirst-lung liquid biopsy test

Sep 12, 2018: Inivata announces senior management change

Appendix

Methodology

About GlobalData

Contact Us

Disclaimer


List Of Figure

List of Figures

Inivata Ltd Pipeline Products by Equipment Type

Inivata Ltd Pipeline Products by Development Stage

Inivata Ltd Ongoing Clinical Trials by Trial Status


List Of Table

List of Tables

Inivata Ltd Pipeline Products and Ongoing Clinical Trials Overview

Inivata Ltd Pipeline Products by Equipment Type

Inivata Ltd Pipeline Products by Indication

Inivata Ltd Ongoing Clinical Trials by Trial Status

Inivata Ltd, Key Facts

Inivata Ltd, Major Products and Services

Inivata Ltd Number of Pipeline Products by Development Stage

Inivata Ltd Pipeline Products Summary by Development Stage

Inivata Ltd Ongoing Clinical Trials by Trial Status

Inivata Ltd Ongoing Clinical Trials Summary

InVision ctDNA Assay-EGFR-Mutant NSCLC-Product Status

InVision ctDNA Assay-EGFR-Mutant NSCLC-Product Description

InVision ctDNA Assay-Metastatic Breast Cancer-Product Status

InVision ctDNA Assay-Metastatic Breast Cancer-Product Description

InVision ctDNA Assay-NSCLC-Product Status

InVision ctDNA Assay-NSCLC-Product Description

InVision ctDNA Assay-NSCLC-Liquid Biopsy in Early Stage NSCLC Resected Lung Tumor Investigation: LIBERTI

InVision ctDNA Assay-Pancreatic Cancer-Product Status

InVision ctDNA Assay-Pancreatic Cancer-Product Description

InVision ctDNA Assay-Stage III/IV NSCLC-Product Status

InVision ctDNA Assay-Stage III/IV NSCLC-Product Description

InVision First-Lung-Product Status

InVision First-Lung-Product Description

InVision First-Lung-A Randomized Phase III Clinical Trial to Evaluate the Feasibility and Clinical Relevance of Liquid Biopsy in Patients with Suspicious Metastatic Lung Cancer

InVision First-Lung-Analytical Validation of a Next Generation Sequencing Liquid Biopsy Assay for High Sensitivity Broad Molecular Profiling

InVision First-Lung-Evaluation of Liquid Biopsies for Molecular Profiling in Patients with Advanced Non-small Cell Lung Cancer (NSCLC) in the Relapse Treatment Setting

Inivata Ltd, Key Employees

Glossary

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

Inivata Ltd, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies


Companies

DiagNodus Ltd

ANGLE Plc

Binx Health Inc